Skip to main content
Download PDF

Alpha‐actinin‐4 is essential for maintaining normal trophoblast proliferation and differentiation during early pregnancy

Reproductive Biology and Endocrinology volume 19, Article number: 48 (2021) Cite this article

Abstract

Background

Proper differentiation of trophoblasts in the human placenta is essential for a successful pregnancy, whereas abnormal regulation of this process may lead to adverse pregnancy outcomes, especially preeclampsia (PE). However, the underlying mechanism of trophoblast differentiation remains unclear. Previous studies have reported the involvement of alpha-actinin-4 (ACTN4) in the actin cytoskeleton dynamics and motility. Hence, we hypothesized that ACTN4 may act as an important regulator in the normal proliferation and differentiation of trophoblasts during early pregnancy.

Method:

To test this hypothesis, we collected villous tissues from women undergoing a legal pregnancy termination during 6–10 weeks of gestation and explanted them for cell culture and siRNA transfection. We also obtained placental tissues from PE patients and healthy pregnant women and isolated the primary cytotrophoblast (CTB) cells. The expression of ACTN4 in the CTBs of placental villi and during the differentiation of CTBs into STBs was detected by immunofluorescence, immunohistochemistry (IHC), and EdU proliferation assays. Besides, villous explant, Matrigel invasion, transwell migration assay, and Wound-healing assay were performed to identify the possible role of ACTN4 in the outgrowth of explants and the invasion, migration, and proliferation of cell column trophoblasts (CCTs). Western blot analysis was carried out to compare the protein expression level of AKT, Snail activities, and epithelial-to-mesenchymal transition (EMT) in the villi or HTR8/SVneo cells with ACTN4 knockdown.

Results

ACTN4 was highly expressed in CTB cells and interstitial extravillous trophoblast (iEVT) cells but not found in the syncytiotrophoblast (STB) cells in the first trimester villi. Downregulation of ACTN4 led to reduced trophoblast proliferation and explant outgrowth ex vivo, as well as iEVT invasion and migration in vitro due to disrupt of actin filaments organization. Such ACTN4 inhibition also decreased AKT and Snail activities and further impeded the EMT process. In addition, ACTN4 expression was found to be downregulated in the iEVTs from preeclamptic placentas.

Conclusions

Our findings suggest that ACTN4 may act as an important regulator of trophoblast proliferation and differentiation during early pregnancy, and dysregulation of this protein may contribute to preeclampsia pathogenesis.

Background

Normal human placental development during the first trimester is considered critical for embryonic survival and maintenance of a healthy pregnancy. The basic structural and functional unit of the placenta is the placental villus [1]. Cytotrophoblast (CTB) progenitors are a layer of mononucleated cells lining the inner portion of the floating placental villi, which can further differentiate into a layer of multinucleated syncytiotrophoblast (STB) cells. CTB cells are known to be implicated in regulating nutrient, water, waste, and gas exchanges between maternal and fetal circulations and producing various hormones vital for fetal development and maintenance of normal pregnancy [2]. Besides, when undergoing an epithelial-to-mesenchymal transition (EMT), proliferative CTBs of the anchoring villi differentiate into extravillous trophoblasts (EVT), thus acquiring a typical motility phenotype to allow for invasion into the maternal uterus [3, 4]. Those trophoblast cells invading the maternal decidua and anchoring the placenta are called interstitial extravillous trophoblasts (iEVTs) [5]. Defective CTB differentiation, particularly in the cases of limited iEVT invasion into the decidua and ensuing failures in remodeling maternal spiral arteries, has been thought to lead to preeclampsia (PE), which is a highly prevalent pregnancy-related complication marked by new-onset hypertension and proteinuria after 20 weeks of gestation resulting in maternal and perinatal morbidity and mortality [6, 7].

EMT is a well-orchestrated process that facilitates invasion through attenuating cell-cell adhesion, reorganizing the actin cytoskeleton, and upregulating the expression of mesenchymal markers [8,9,10]. Cell motility and invasion are essential activities involved in the dramatic changes in cellular morphology associated with dynamic cytoskeleton remodeling [11]. Importantly, successful cellular invasion depends on the emergence of invasive structures [12, 13], suggesting that cytoskeletal integrity is critical for EMT-induced migration and invasion of EVTs.

Alpha-actinins (ACTNs) are known to maintain the cytoskeletal structure and modulate cell motility [14]. Among the four members of the ACTN family in humans, ACTN2 and ACTN3 are muscle-specific and are predominantly localized in the Z lines of striated muscle cells, while ACTN1 and ACTN4 are ubiquitously expressed. All these actinins share high sequence homology. In contrast to ACTN1, which is mainly expressed at cell-cell adherens junctions, ACTN4 is predominantly found at the leading edge of moving cells [15, 16], suggesting that ACTN4 may be involved in cell migration. In addition, ACTN4 signaling connects integrin with the actin cytoskeleton and potentiates trophoblast invasion in bovine placentas [17]. A recent investigation revealed that ACTN4 is highly expressed in EVTs based on the microarray data from the gene expression omnibus database [18]. Furthermore, ACTN4 deficiency has been reported to dramatically attenuate the proliferation and invasion of various cancer cells [19,20,21]. The accumulating evidence strongly implies that ACTN4 may participate in trophoblast proliferation and invasion. However, the true functions of ACTN4 in trophoblast and placental development remain obscure.

Given the role of this protein in the actin cytoskeleton dynamics and motility, we hypothesized that ACTN4 is crucial for successful trophoblast invasion and migration, and ACTN4 deficiency may ultimately contribute to poor placentation and PE development.

Materials and Methods

Sample collection

Villous tissues were collected from women who underwent a legal pregnancy termination for non-medical reasons at the first trimester of gestation (6–10 weeks). Those with a history of spontaneous abortion or ectopic pregnancy were excluded. Placental tissues were obtained at the maternal side from women with normal pregnancies and patients with PE (defined as a new onset of hypertension (systolic/diastolic blood pressure ≥ 160/110 mmHg measured on two occasions at least 4 h apart) and proteinuria after 20 weeks of gestation) during cesarean deliveries. Patients with other pregnancy-related complications were also excluded. A portion of biopsies was immediately snap frozen in liquid nitrogen and stored at − 80 °C for later use, while the remaining tissues were fixed in 4 % paraformaldehyde and then embedded in paraffin. The patients’ clinical features are summarized in Table 1. For all samples, written informed consent was obtained, and this research was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University.

Table 1 Clinical characteristics of the subjects
Full size table

Cells, villous explant culture, and siRNA transfection

The immortalized human trophoblast cell lines, HTR8/SVneo (American Type Culture Collection, Manassas, VA, USA), were cultured in RPMI-1640 (Gibco, Carlsbad, CA, USA) medium supplemented with 10 % fetal bovine serum (FBS; Gemini, California, USA) under standard conditions (37 °C, 5 % CO2, humidified atmosphere). si-ACTN4 (50 nM, 5′-GUUCAUCGUCCAUACCAUC-3′ [22]) and a negative control siRNA were synthesized by GenePharma, Inc. (Shanghai, China). The siRNAs were used to transfect the HTR8/SVneo cells with Lipofectamine™ 3000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. The collected first trimester villi were sectioned at 2–5 mm, seeded into 24-well plates, precoated with Matrigel (1 µg/µL), and then cultured with DMEM/F12 medium containing 10 % FB before transfection with 500 nM si-ACTN4. The explant outgrowth on the Matrigel was recorded using the EVOS FL Color Imaging System (Thermo Fisher Scientific, Waltham, USA).

Isolation of primary cytotrophoblast cells

CTBs were isolated from human term placentas as previously described [23]. Briefly, the placental tissues were enzymatically digested through incubation with dispase (Worthington, Lakewood, NJ, USA), 0.25 % trypsin (Gibco), and 0.02 % DNase (Sigma, Missouri, USA) in a 37 °C water bath for 45 min in a way to remove the outer syncytium layer and release the underlying CTBs. Cells were purified via centrifugation at 1400 rpm for 30 min on a 40 % Percoll gradient (GE Healthcare Biosciences, USA) that had been diluted in 10 % 10×HBSS buffer (diluted in ddH2O) and pre-centrifuged at 15,000 rpm for 50 min. The cytotrophoblast layer was just above the red blood cell layer. The isolated CTBs were incubated at 37 °C, 5 % CO2 for 3 h to allow for cell adhesion or for 48 h to allow for cell syncytialization.

Immunohistochemistry

The tissue samples were fixed with 4 % paraformaldehyde at room temperature and embedded in paraffin before sectioning at 4 μm. The obtained sections were then deparaffinized in xylene, rehydrated in a serial ethanol gradient, and blocked with 3 % H2O2 for 10 min. Antigen retrieval was performed through microwaving in 10 mM citric sodium (pH 6.0) for 15 min. Subsequently, the sections were incubated with a rabbit polyclonal primary antibody against ACTN4 (1:200, Proteintech, Wuhan, China), a mouse monoclonal antibody against CK7 (1:100, Abcam, Cambridge, UK), or a mouse monoclonal antibody against HLA-G (1:100, Proteintech) overnight at 4 °C. The secondary antibodies conjugated to horseradish peroxidase were then added for 30 min at room temperature, followed by additional incubation with DAB solution for visualization. The sections were subsequently counterstained with haematoxylin (Nanjing JianCheng Bioengineering Institute, Nanjing, China).

Immunofluorescence staining

Cells were fixed with 4 % paraformaldehyde, permeabilized in 0.2 % Triton X-100, and then incubated with the indicated antibodies overnight at 4 °C prior to further incubation with FITC-conjugated or Cy3-conjugated goat anti-rabbit or mouse fluorescent antibodies (Proteintech, 1:100) at room temperature for 1 h. For actin filament staining, permeabilized cells were incubated with 100 nM TRITC-phalloidin (Solarbio, Beijing, China) solutions directly for 30 min at room temperature. The nuclei were stained with DAPI, and images were visualized using the EVOS FL Color Imaging System (Thermo Fisher Scientific).

Western blotting

Protein extracts were prepared from the tissues and cells using a RIPA lysis buffer supplemented with PMSF (Beyotime Institute of Biotechnology, Jiangsu, China), protein concentrations were measured using a bicinchoninic acid (BCA) Protein Assay kit (Beyotime). Equal amounts of protein were separated by SDS-polyacrylamide gel electrophoresis (Bio-Rad Laboratories, Hercules, California, USA), and then transferred onto PVDF membranes (Millipore, Darmstadt, Germany). Following blocking with 5 % nonfat dry milk (Bio-Rad) at room temperature for 1 h, the membranes were immunoblotted overnight at 4 °C with primary antibodies against ACTN4 (1:3000, Proteintech), GCM-1(1:500, Proteintech), AKT (1:1000, Abcam), AKT phosphorylated at serine 473 (1:1000, Cell Signaling Technology, Danvers, MA, USA), p-GSK3β (1:1000, Cell Signaling Technology), Snail (1:1000, Cell Signaling Technology), N-cadherin (1:1000, Cell Signaling Technology), Vimentin (1:1000, Abcam), or β-actin (1:1000, Proteintech). After the membranes were rinsed with TBST, another incubation with the respective HRP-conjugated secondary antibodies (1:5000, Zhong San Golden Bridge Crop, Beijing, China) was carried out at room temperature for 1 h. Immunoreactive bands were detected using an enhanced chemiluminescent substrate (Millipore), and the images were captured and analyzed using the ChemiDoc XRS + system (Bio-Rad).

Matrigel invasion and transwell migration assay

The invasion ability was measured using a transwell chamber consisting of a 24-well plate with membrane inserts (Corning, New York, USA) containing polycarbonate filters (pore size: 8 μm) that were precoated with 60 µL of 1 mg/mL Matrigel matrix solution (BD Biosciences, California, USA). A suspension of 8 × 104 cells in 200 µL of serum-free culture medium was added to the inserts, which were then placed in the lower chamber containing 600 µL of 10 % FBS culture medium. The cells were left to migrate through the membranes for 24 h prior to fixing with 4 % paraformaldehyde and staining with crystal violet. Images were captured using the EVOS FL Color Imaging System (Thermo Fisher Scientific). The cell migration assay was performed in the same manner, except that the inserts were not coated with Matrigel.

EdU proliferation assay

A total of 100 µL of EdU culture medium (1:1000, 50 µM) was added to each well of the villous explants for 12 h, followed by fixing with 4 % formaldehyde for 30 min, paraffin embedding, and sectioning at 4 μm. After intensive washing, the tissue sections were subjected to a Click-iTR EdU Kit (RiboBio, Guangzhou, China) for 30 min and stained with 100 µL of DAPI (RiboBio) at room temperature for 30 min. Image analysis was performed on a fluorescence microscope (EVOS FL Color Imaging System). The relative percentage of EdU-positive cells was determined by examining three to five samples in three wells.

Wound‐healing assay

Cells were grown to confluence on a 6-well plate and then mechanically scratched with a sterile pipette tip. After removal of the non-adherent cells via rinsing with PBS, the remaining cells were grown in serum-free 1640 medium with ACTN4 siRNA for an additional 24 h. The cell motility, i.e., wound closure, was measured by photographing three random fields at the 0 and 24 h time points.

Statistical analysis

Data are presented as the means ± SEM. Statistical data were analyzed using Student’s t-tests (a significance level of p < 0.05). All statistical analyses were performed using GraphPad Prism 7 software (La Jolla, California, USA).

Results

ACTN4 was highly expressed in the CTBs of placental villi

Following the idea that ACTN4 may have an ever-emerging role in human placentation, we first detected the expression pattern of ACTN4 in the first trimester villi by immunohistochemistry and identified CTBs with the use of an anti-CK7 antibody. The results showed that ACTN4 was strongly expressed in the CTBs of the first trimester villi, while no obvious staining was detected in the STBs (Fig. 1 A). Owing to the recent finding that CTB proliferation and trophoblast stemness are responsible for early placental development [24, 25], we next explored the role of ACTN4 in trophoblast proliferation. This was accomplished by treatment of the first trimester villous explants with a siRNA that specifically targeted the mRNA of ACTN4. Immunofluorescence analyses revealed that ACTN4 downregulation reduced EdU labeling of the CTBs in floating villous explants (Fig. 1B). These data suggested that ACTN4 may be involved in trophoblast proliferation.

Fig. 1
figure 1

ACTN4 expression in placental CTBs. a IHC staining of ACTN4 in the human first trimester placenta villi. CTBs were stained for CK7; Scale bars: 100 μm. b EdU labeling in explant cultures. Villous explants isolated from the first trimester placentas were treated with the control siRNA (si-NC) or ACTN4 siRNA (si-ACTN4). Representative pictures showed EdU (pink) labeling in the villous cytotrophoblasts of floating villi following 72-h treatment. Nuclei were counterstained with DAPI (blue). Scale bars: 100 μm. All data are presented as the means ± SEM of three independent experiments. *p < 0.05

Full size image

ACTN4 was downregulated during the differentiation of CTBs into STBs

STBs arise by fusion of the CTBs with proliferative properties, and DNA synthesis is found absent in the human STB cells [26], demonstrating that the differentiation from CTBs into STBs occurs simultaneously with the loss of cell proliferation abilities. Our above-mentioned finding that downregulation of ACTN4 decreased trophoblast proliferation revealed that CTB differentiation into STBs may be accompanied by a reduced ACTN4 expression. To test this hypothesis, we isolated the primary CTBs from term placentas and allowed them to differentiate into STBs in a gradual, spontaneous manner during 48 h of in vitro culture. The results showed that ACTN4 was strongly stained and expressed in the primary CTBs but barely detected during the course of differentiation (Fig. 2), suggesting that ACTN4 was downregulated in the CTB loss of proliferative abilities. Taken together, these data further confirmed that ACTN4 may play a pivotal role in CTB proliferation.

Fig. 2
figure 2

ACTN4 expression in the process of CTB differentiation into STBs. a Immunofluorescence staining for ACTN4 (red) and CK7 (green) in the freshly isolated primary human CTB cells. Staining was performed after 3 or 48 h of culture. Nuclei were counterstained with DAPI (blue). White dashed circles and white arrows indicate syncytialized cells and unsyncytialized cells, respectively. Scale bars: 100 μm. b Western blotting for ACTN4 and GCM-1 (a syncytiotrophoblast marker) in the primary human CTB cells after 3 or 48 h of culture. All data are presented as the means ± SEM of three independent experiments. **P < 0.01; ***P < 0.001

Full size image

ACTN4 deficiency reduced proliferation of cell column trophoblasts and outgrowth of extravillous explants

In addition to the high expression in CTBs, ACTN4 was also strongly stained in the HLA-G-labeled CCTs in the first trimester villi, with an increased expression level spotted at the distal region where the cells transformed into iEVTs after undergoing an EMT process (Fig. 3 a). Immunofluorescence analyses revealed that the knockdown of ACTN4 led to a declined EdU labeling of CCTs in the anchoring villous explants (Fig. 3b). Moreover, inhibited ACTN4 was found to reduce the outgrowth distance of Matrigel-seeded villous explants (Fig. 3 c). These results demonstrated that loss of ACTN4 impedes the outgrowth of villous explants by reducing CCT proliferation.

Fig. 3
figure 3

Role of ACNT4 in villous explants outgrowth. a IHC staining of ACTN4 in the human first trimester placenta villi. iEVTs were stained for HLA-G. Scale bars: 200 μm. b EdU labeling in explant cultures. Representative pictures showed EdU (pink) labeling in the CCTs of the anchoring villi after 72-h treatment of ACNT4 with siRNA. Nuclei were counterstained with DAPI (blue). Scale bars: 100 μm. c Outgrowth of induced EVTs in a villous explant culture model. Left panel, bright and fluorescent field views showing that small interfering RNA labeled with FAM successfully penetrated the villous explants. Right panel, the outgrowth of induced EVTs from villous explants treated with control siRNA (si-NC) or ACTN4 siRNA (si-ACTN4) for 24 and 48 h. Scale bar: 1000 μm. All data are presented as the means ± SEM of three independent experiments, *P < 0.05; **P < 0.01

Full size image

Inhibition of ACTN4 decreased HTR8/SVneo cell invasion and migration

Since ACTN4 is highly abundant in iEVTs and the major function of the latter is to migrate and invade into the maternal decidua [27], we proceeded to verify whether ACTN4 has a significant role in cell invasion and migration. First, TRITC-phalloidin staining showed that the organization of actin filaments (F-actin) was disrupted in ACTN4 silenced of HTR8/SVneo cell (Fig. 4 a). Then, the Matrigel cell invasion and transwell cell migration assay results showed that ACTN4-deficient cells displayed lower invasion and migration abilities than the control cells (Fig. 4b). Furthermore, wound-healing assays confirmed that the knockdown of ACTN4 markedly inhibited cell migration (Fig. 4 c). These findings altogether indicated that ACTN4 deficiency attenuates iEVT invasion and migration during placentation.

Fig. 4
figure 4

Effects of ACTN4 on HTR8/SVneo cell invasion and migration. a TRITC-Phalloidin staining on si-NC and si-ACTN4 of HTR8/SVneo cells. Scale bar, 200 μm. b Representative images and quantification of cells from the HTR8/SVneo cells with invasion in the presence or absence of a Matrigel-coated membrane for 24 h. Scale bar: 200 μm. c HTR8/SVneo cells attached to the culture plates after wounding and treatment with ACTN4 siRNA. The percentage of wound closure was calculated at 24 h. Scale bar: 400 μm. All data are presented as the means ± SEM of three independent experiments. **P < 0.01

Full size image

AKT activation and Snail expression were involved in the ACTN4-induced proliferation, invasion, and migration of trophoblasts

To investigate the regulatory mechanism of ACTN4 in trophoblast function, we first examined the role of ACTN4 in regulating the AKT pathway in the first trimester villi. Western blot analyses suggested that ACTN4 knockdown reduced AKT phosphorylation at Ser473; accordingly, the phosphorylation level of its downstream effector GSK3β was also remarkably declined (Fig. 5). Moreover, ACTN4 silencing inhibited the expression level of Snail, a transcription factor that potentiates the EMT process, and an evident reduction was also noted in the Snail-modulated mesenchymal marker vimentin (Fig. 5). Whereas, another mesenchymal marker, N-cadherin, had no significant expression alterations in the ACTN4 knockdown group. The same results were also observed for the HTR8/SVneo cells. From these data, we concluded that ACTN4 might regulate trophoblast proliferation, invasion, and migration through the AKT/GSK3β/Snail pathway.

Fig. 5
figure 5

ACTN4 regulation of the AKT/GSK3β/Snail pathway in trophoblasts. Western blotting for ACTN4, p-AKTSer473, AKT, p-GSK3β, Snail, N-cadherin, and Vimentin in the first trimester villi (left panel) and HTR-8/SVneo cells (right panel) transfected with si-NC or si-ACTN4 for 72 h. All data are presented as the means ± SEM of three independent experiments. *P < 0.05; **P < 0.01

Full size image

ACTN4 was hardly detectable in the iEVTs of sPE placentas

Shallow invasion of iEVTs into the maternal decidua has been widely recognized as the primary cause of PE development [6]. In this context, we proceeded to examine the expression pattern of ACNT4 in the iEVTs of normal and sPE placentas. IHC assays showed that ACTN4-positive staining was observed in the HLA-G-labeled iEVTs on the maternal side of full-term normal placentas but barely detected in the sPE placentas (Fig. 6 a). Subsequently, we compared the expression level of ACTN4 in those placentas by Western blotting. Interestingly, the ACTN4 level was found significantly lower in the sPE placentas than in the normal controls (Fig. 6b).

Fig. 6
figure 6

ACTN4 expression in the iEVTs from sPE placentas. a IHC staining of ACTN4 on the maternal side of normal and sPE placentas. Staining was performed on serial sections; iEVTs were stained for HLA-G. DS: decidual side. Scale bars: 200 μm. b Western blotting for ACTN4 on the maternal side of normal and sPE placentas. All data are presented as the means ± SEM of three independent experiments. ***P < 0.001

Full size image

Discussion

Proper development of the placenta and its component lineages at early stages is critical for successful pregnancy [28]. Dysregulation of EVTs disrupts the normal invasion of trophoblasts into the uterus, which consequently leads to incomplete spiral artery remodeling and placental hypoperfusion [29]. In the current study, ACTN4 was predominantly expressed in the CTBs and iEVTs from normal placentas but barely detected in those cells from sPE placentas. Downregulation of ACTN4 reduced villous trophoblast proliferation and explant outgrowth ex vivo. In addition, ACTN4 deficiency resulted in significant inhibition of cell invasion and motility. Such attenuated proliferation, invasion, and migration was a result of ACTN4-mediated inactivation of the AKT/GSK3β/Snail pathway. CTBs are the so-called epithelial stem cells of the placenta, which, depending on the signals they receive, can maintain the balance between their differentiation into either STBs or EVTs [30]. Additionally, isolated CTBs without proliferative capabilities can spontaneously differentiate into STBs following 24-h culture [31], suggesting that the self-renewal potential of CTBs are essential for maintaining the proliferation and differentiation abilities. Our IHC data and primary CTB culture studies revealed that ACTN4 was highly expressed in CTBs but not in STBs, and a downregulated ACTN4 expression level reduced CTB proliferation and explant outgrowth, indicating that ACTN4 deficiency may facilitate STB fusion but is detrimental to EVT development. As previously reported [32], ACTN4 is a functional partner of AKT, and thus ACTN4 silencing inhibits AKT membrane translocation and phosphorylation, which results in a significant reduction in cell proliferation. Moreover, ACTN4 downregulation contributed to diminished AKT phosphorylation in both villous explants and HTR8/SVneo cells. Based on these observations, we believe that ACTN4 exerts an impact on CTB proliferation by modulating AKT activation.

Although ACTN4 is frequently expressed in the distal region of CCTs and iEVTs, the exact role of ACTN4 in CCTs undergoing EMT remains unknown. In the present study, we found that ACTN4 knockdown decreased AKT and GSK3β phosphorylation and the expression of Snail. Snail has a pivotal part in the modulation of EMT and is involved in tumorigenesis via repression of epithelial marker proteins and induction of mesenchymal marker proteins [33, 34]. Our results revealed that ACTN4 downregulation impeded EMT progression by suppressing the expression of EMT-associated proteins, such as Snail and Vimentin, resulting in abnormal trophoblast invasion and migration. Additionally, the EMT process includes cytoskeleton remodeling [35], and ACTN4 is a cytoskeletal protein that is primarily localized in the filopodia extension and involved in the extension of podosomes during cell invasion and migration [36, 37]. Moreover, ACTN4 dysregulation leads to the disassembly and disruption of actin filament-based structures, such as filopodia and podosomes [38,39,40]. This evidence indicated that ACTN4 silencing may lead to the disorganization of actin filaments via the EMT approach, and, ultimately, impaired filopodia and podosome formation result in inadequate EVT invasion and migration.

Conclusions

Our findings suggest that the appropriate expression of ACTN4 is essential for normal proliferation and differentiation of CTBs during early pregnancy. ACTN4 downregulation may result in inadequate trophoblast proliferation, invasion, and migration through the mediation of the AKT/GSK3β/Snail pathway. Besides, dysregulation of this protein may contribute to preeclampsia.

Availability of data and materials

All data generated through this study are included in this article.

Abbreviations

CTB:

cytotrophoblasts

STB:

syncytiotrophoblast

EMT:

epithelial-to-mesenchymal transition

EVT:

extravillous trophoblasts

ACTNs:

Alpha-actinins

IHC:

Immunohistochemistry

References

  1. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev. 2006;27(2):141–69.

    Article  Google Scholar 

  2. Renaud SJ, Chakraborty D, Mason CW, Rumi MA, Vivian JL, Soares MJ. OVO-like 1 regulates progenitor cell fate in human trophoblast development. Proc Natl Acad Sci U S A. 2015;112(45):E6175-84.

    Article  Google Scholar 

  3. Knofler M, Pollheimer J. IFPA Award in Placentology lecture: molecular regulation of human trophoblast invasion. Placenta. 2012;33(Suppl):55–62.

    Article  Google Scholar 

  4. DaSilva-Arnold S, James JL, Al-Khan A, Zamudio S, Illsley NP. Differentiation of first trimester cytotrophoblast to extravillous trophoblast involves an epithelial-mesenchymal transition. Placenta. 2015;36(12):1412–8.

    Article  CAS  Google Scholar 

  5. Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol. 2006;46(4):266–73.

    Article  Google Scholar 

  6. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004;114(6):744–54.

    Article  CAS  Google Scholar 

  7. Reynolds LP, Redmer DA. Angiogenesis in the placenta. Biol Reprod. 2001;64(4):1033–40.

    Article  CAS  Google Scholar 

  8. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–96.

    Article  CAS  Google Scholar 

  9. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.

    Article  CAS  Google Scholar 

  10. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6):1438–49.

    Article  CAS  Google Scholar 

  11. Dart AE, Gordon-Weeks PR. The Role of Drebrin in Cancer Cell Invasion. Adv Exp Med Biol. 2017;1006:375–89.

    Article  CAS  Google Scholar 

  12. Parast MM, Aeder S, Sutherland AE. Trophoblast giant-cell differentiation involves changes in cytoskeleton and cell motility. Dev Biol. 2001;230(1):43–60.

    Article  CAS  Google Scholar 

  13. Patel A, Dash PR. Formation of atypical podosomes in extravillous trophoblasts regulates extracellular matrix degradation. Eur J Cell Biol. 2012;91(3):171–9.

    Article  CAS  Google Scholar 

  14. Sjoblom B, Salmazo A, Djinovic-Carugo K. Alpha-actinin structure and regulation. Cell Mol Life Sci. 2008;65(17):2688–701.

    Article  CAS  Google Scholar 

  15. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, et al. Differential expression of the actin-binding proteins, alpha-actinin-2 and – 3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet. 2001;10(13):1335–46.

    Article  CAS  Google Scholar 

  16. Hamill KJ, Hopkinson SB, Skalli O, Jones JC. Actinin-4 in keratinocytes regulates motility via an effect on lamellipodia stability and matrix adhesions. FASEB J. 2013;27(2):546–56.

    Article  CAS  Google Scholar 

  17. Bridger PS, Haupt S, Leiser R, Johnson GA, Burghardt RC, Tinneberg HR, et al. Integrin activation in bovine placentomes and in caruncular epithelial cells isolated from pregnant cows. Biol Reprod. 2008;79(2):274–82.

    Article  CAS  Google Scholar 

  18. Liu Y, Fan X, Wang R, Lu X, Dang YL, Wang H, et al. Single-cell RNA-seq reveals the diversity of trophoblast subtypes and patterns of differentiation in the human placenta. Cell Res. 2018;28(8):819–32.

    Article  CAS  Google Scholar 

  19. Fu L, Qin YR, Ming XY, Zuo XB, Diao YW, Zhang LY, et al. RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer. Proc Natl Acad Sci U S A. 2017;114(23):E4631-E40.

    Article  Google Scholar 

  20. Zhang YY, Tabataba H, Liu XY, Wang JY, Yan XG, Farrelly M, et al. ACTN4 regulates the stability of RIPK1 in melanoma. Oncogene. 2018.

  21. Wang N, Wang Q, Tang H, Zhang F, Zheng Y, Wang S, et al. Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of beta-catenin stabilization in cancer stem cells. J Exp Clin Cancer Res. 2017;36(1):172.

    Article  Google Scholar 

  22. Hayashida Y, Honda K, Idogawa M, Ino Y, Ono M, Tsuchida A, et al. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res. 2005;65(19):8836–45.

    Article  CAS  Google Scholar 

  23. Peng W, Tong C, Li L, Huang C, Ran Y, Chen X, et al. Trophoblastic proliferation and invasion regulated by ACTN4 is impaired in early onset preeclampsia. FASEB J. 2019:fj201802058RR.

  24. Horii M, Moretto-Zita M, Nelson KK, Li Y, Parast MM. MTA3 regulates differentiation of human cytotrophoblast stem cells. Placenta. 2015;36(9):974–80.

    Article  CAS  Google Scholar 

  25. Haider S, Meinhardt G, Saleh L, Kunihs V, Gamperl M, Kaindl U, et al. Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta. Stem Cell Reports. 2018;11(2):537–51.

    Article  CAS  Google Scholar 

  26. Lu X, Wang R, Zhu C, Wang H, Lin HY, Gu Y, et al. Fine-Tuned and Cell-Cycle-Restricted Expression of Fusogenic Protein Syncytin-2 Maintains Functional Placental Syncytia. Cell Rep. 2017;21(5):1150–9.

    Article  CAS  Google Scholar 

  27. Ji L, Brkic J, Liu M, Fu G, Peng C, Wang YL. Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. Mol Aspects Med. 2013;34(5):981–1023.

    Article  CAS  Google Scholar 

  28. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet. 2001;2(7):538–48.

    Article  CAS  Google Scholar 

  29. James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol. 2010;221(4):363–78.

    Article  CAS  Google Scholar 

  30. Chang CW, Wakeland AK, Parast MM. Trophoblast lineage specification, differentiation and their regulation by oxygen tension. J Endocrinol. 2018;236(1):R43–56.

    Article  CAS  Google Scholar 

  31. Zhang M, Muralimanoharan S, Wortman AC, Mendelson CR. Primate-specific miR-515 family members inhibit key genes in human trophoblast differentiation and are upregulated in preeclampsia. Proc Natl Acad Sci U S A. 2016.

  32. A retrovirus-based. protein complementation assay screen reveals functional AKT1-binding partners. PNAS. 2006.

  33. Medici D, Hay ED, Olsen BR. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell. 2008;19(11):4875–87.

    Article  CAS  Google Scholar 

  34. Ohkubo T, Ozawa M. The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci. 2004;117(Pt 9):1675–85.

    Article  CAS  Google Scholar 

  35. Topal T, Hong X, Xue X, Fan Z, Kanetkar N, Nguyen JT, et al. Acoustic Tweezing Cytometry Induces Rapid Initiation of Human Embryonic Stem Cell Differentiation. Sci Rep. 2018;8(1):12977.

    Article  Google Scholar 

  36. Shao H, Wang JH, Pollak MR, Wells A. alpha-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS One. 2010;5(11):e13921.

    Article  Google Scholar 

  37. Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F, et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology. 2005;128(1):51–62.

    Article  CAS  Google Scholar 

  38. Yamaguchi H, Ito Y, Miura N, Nagamura Y, Nakabo A, Fukami K, et al. Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells. Eur J Cell Biol. 2017;96(7):685–94.

    Article  CAS  Google Scholar 

  39. Ge H, Yu A, Chen J, Yuan J, Yin Y, Duanmu W, et al. Poly-L-ornithine enhances migration of neural stem/progenitor cells via promoting alpha-Actinin 4 binding to actin filaments. Sci Rep. 2016;6:37681.

    Article  CAS  Google Scholar 

  40. Khurana S, Chakraborty S, Lam M, Liu Y, Su YT, Zhao X, et al. Familial focal segmental glomerulosclerosis (FSGS)-linked alpha-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. J Biol Chem. 2012;287(15):12027–35.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Junwei Gu for technical assistance in the primary CTB isolation. We also appreciate the “111 program” support from the Ministry of Education and the State Administration of Foreign Experts Affairs of the People’s Republic of China.

Funding

This work was supported by the National Natural Science Foundation of China (82001582, 81771613, 81771614, 82001581, 81671488, 81601305, 81601304) and the Natural Science Foundation of Chongqing (cstc2019jcyj-msxm0856).

Author information

Author notes

  1. Wei Peng and Ying Liu contributed equally to this work.

Authors and Affiliations

  1. Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, 400016, Chongqing, China

    Wei Peng, Ying Liu & Hongbo Qi

  2. Chongqing Key Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, 400016, Chongqing, China

    Wei Peng, Ying Liu, Hongbo Qi & Qingshu Li

  3. Joint International Research Laboratory of Reproduction and Development of Chinese Ministry of Education, Chongqing Medical University, 400016, Chongqing, China

    Wei Peng, Ying Liu, Hongbo Qi & Qingshu Li

  4. Department of Pathology, School of Basic Medicine, Chongqing Medical University, 1 Yixueyuan Rd, Yuzhong District, 400016, Chongqing, China

    Qingshu Li

Authors
  1. Wei Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongbo Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qingshu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: W.P., H.B.Q., and Q.S.L. Development of methodology: W.P., Y.L., Q.S.L. Acquisition of data: W.P., Y.L. Q.S.L. Analysis and interpretation of data: W.P., Y.L. Drafting the article: W.P., Y.L., H.B.Q., Q.S.L. All authors approved the final version and submission of this article.

Corresponding author

Correspondence to Qingshu Li.

Ethics declarations

Ethics approval and consent to participate

This research was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University. Written informed consent was obtained from all participants before study enrollment.

Consent for publication

All authors have consented to the publication of this article.

Competing interests

The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Wei Peng and Ying Liu are co-first authors.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, W., Liu, Y., Qi, H. et al. Alpha‐actinin‐4 is essential for maintaining normal trophoblast proliferation and differentiation during early pregnancy. Reprod Biol Endocrinol 19, 48 (2021). https://doi.org/10.1186/s12958-021-00733-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12958-021-00733-0

Keywords

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us